Krynica Vitamin S.A. (WSE:KVT)
Poland · Delayed Price · Currency is PLN 13.15
0.00 (0.00%)
Sep 24, 2026, 5:51 PM CET
Krynica Vitamin Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 373.59 | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 |
Other Revenue | - | - | - | - | - | 0 |
| 373.59 | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 | |
Revenue Growth | -3.35% | -8.15% | 8.62% | -5.31% | -4.59% | -11.35% |
Cost of Revenue | 309.7 | 295.75 | 323.54 | 304.63 | 310.91 | 336.78 |
Gross Profit | 63.9 | 60.53 | 64.36 | 52.49 | 66.25 | 58.53 |
Selling, General & Admin | 42.21 | 40.61 | 48.5 | 44.66 | 44.87 | 40.28 |
Other Operating Expenses | 0.65 | -1.69 | -3.34 | -0.77 | 0.51 | -5.14 |
Operating Expenses | 42.86 | 38.92 | 45.17 | 43.88 | 45.38 | 35.15 |
Operating Income | 21.04 | 21.61 | 19.19 | 8.61 | 20.88 | 23.39 |
Interest Expense | -1.88 | -2.07 | -3.62 | -4.32 | -3.56 | -0.91 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0.08 |
Other Non Operating Income (Expenses) | -1.06 | 0.27 | 0.62 | 0.62 | 1.02 | 1.3 |
EBT Excluding Unusual Items | 18.1 | 19.82 | 16.19 | 4.91 | 18.34 | 23.86 |
Gain (Loss) on Sale of Assets | -0.18 | 0.07 | 0.04 | 0.09 | -0.05 | -0.06 |
Asset Writedown | -5.44 | -5.06 | -2.42 | 0.37 | -4.14 | -2.8 |
Other Unusual Items | - | - | - | -12.1 | - | - |
Pretax Income | 12.48 | 14.83 | 13.81 | -6.74 | 14.15 | 21 |
Income Tax Expense | 2.03 | 2.88 | 1.58 | -0.05 | 1.07 | 5.42 |
Net Income | 10.45 | 11.95 | 12.23 | -6.68 | 13.08 | 15.58 |
Net Income to Common | 10.45 | 11.95 | 12.23 | -6.68 | 13.08 | 15.58 |
Net Income Growth | -28.13% | -2.29% | - | - | -16.05% | -72.63% |
Shares Outstanding (Basic) | - | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | - | 12 | 12 | 12 | 12 | 12 |
Shares Change | - | -0.02% | - | - | - | - |
EPS (Basic) | - | 0.98 | 1.00 | -0.55 | 1.07 | 1.27 |
EPS (Diluted) | - | 0.98 | 1.00 | -0.55 | 1.07 | 1.27 |
EPS Growth | - | -2.27% | - | - | -16.05% | -72.63% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8.02 | 24.75 | 20.19 | 13.68 | -1.75 | -7.41 |
Free Cash Flow Per Share | - | 2.02 | 1.65 | 1.12 | -0.14 | -0.60 |
Dividend Per Share | - | - | 0.270 | - | 0.200 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 17.10% | 16.99% | 16.59% | 14.70% | 17.57% | 14.81% |
Operating Margin | 5.63% | 6.07% | 4.95% | 2.41% | 5.54% | 5.92% |
Profit Margin | 2.80% | 3.35% | 3.15% | -1.87% | 3.47% | 3.94% |
Free Cash Flow Margin | 2.15% | 6.95% | 5.21% | 3.83% | -0.46% | -1.87% |
EBITDA | 35.25 | 36.11 | 32.81 | 22.79 | 33.53 | 35.94 |
EBITDA Margin | 9.44% | 10.14% | 8.46% | 6.38% | 8.89% | 9.09% |
D&A For EBITDA | 14.22 | 14.5 | 13.62 | 14.18 | 12.66 | 12.55 |
EBIT | 21.04 | 21.61 | 19.19 | 8.61 | 20.88 | 23.39 |
EBIT Margin | 5.63% | 6.07% | 4.95% | 2.41% | 5.54% | 5.92% |
Effective Tax Rate | 16.25% | 19.40% | 11.44% | - | 7.55% | 25.81% |
Revenue as Reported | 373.59 | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 |